155 tracked 13F filers disclose a position in RNA as of the latest SEC 13F filings, a combined $191.9M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | PRICE T ROWE ASSOCIATES INC /MD/ | $20.8M | 1.6M | ▲New +1.6M sh | Q1 2026 | |
| 2 | BlackRock, Inc. | $16.1M | 1.2M | ▲New +1.2M sh | Q1 2026 | |
| 3 | RA CAPITAL MANAGEMENT, L.P. | $11.6M | 864K | ▲New +864K sh | Q1 2026 | |
| 4 | CRCM LP | $8.6M | 642K | ▲New +642K sh | Q2 2026 | |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | $8.4M | 627K | →First observed position No prior filed position | Q1 2026 | |
| 6 | TIG Advisors, LLC | $8.1M | 608K | ▲New +608K sh | Q1 2026 | |
| 7 | Pentwater Capital Management LP | $8.1M | 603K | ▲New +603K sh | Q1 2026 | |
| 8 | Sessa Capital IM, L.P. | $7.4M | 551K | ▲New +551K sh | Q1 2026 | |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | $5.2M | 387K | ▲+21% Added · +67K sh | Q2 2026 | |
| 10 | GOLDMAN SACHS GROUP INC | $4.7M | 350K | ▲New +350K sh | Q1 2026 | |
| 11 | FARALLON CAPITAL MANAGEMENT LLC | $4.7M | 349K | ▲New +349K sh | Q1 2026 | |
| 12 | VANGUARD PORTFOLIO MANAGEMENT LLC | $4.6M | 344K | →First observed position No prior filed position | Q1 2026 | |
| 13 | 683 Capital Management, LLC | $4.0M | 300K | —Held | Q2 2026 | |
| 14 | STATE STREET CORP | $3.7M | 272K | ▲+5.7% Added · +15K sh | Q2 2026 | |
| 15 | CANTOR FITZGERALD, L. P. | $3.2M | 236K | ▲New +236K sh | Q1 2026 | |
| 16 | BALYASNY ASSET MANAGEMENT L.P. | $3.1M | 235K | ▲New +235K sh | Q1 2026 | |
| 17 | Squarepoint Ops LLC | $3.1M | 231K | ▲New +231K sh | Q1 2026 | |
| 18 | Weiss Asset Management LP | $3.0M | 220K | ▼−8.7% Reduced · −21K sh | Q2 2026 | |
| 19 | Schonfeld Strategic Advisors LLC | $2.7M | 199K | ▲+22% Added · +36K sh | Q2 2026 | |
| 20 | MILLENNIUM MANAGEMENT LLC | $2.6M | 191K | ▲New +191K sh | Q1 2026 | |
| 21 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $2.5M | 184K | ▲New +184K sh | Q1 2026 | |
| 22 | Slotnik Capital, LLC | $2.4M | 181K | ▲New +181K sh | Q1 2026 | |
| 23 | AQR Arbitrage LLC | $2.4M | 180K | ▲New +180K sh | Q1 2026 | |
| 24 | TWO SIGMA INVESTMENTS, LP | $2.4M | 179K | ▲New +179K sh | Q1 2026 | |
| 25 | MORGAN STANLEY | $2.2M | 165K | ▲New +165K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 48 funds opened a new position in RNA and 5 added to an existing one, while 2 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ELECTRONIC ARTS INCEA | 70 funds | $7.7B |
| WARNER BROS DISCOVERY INCWBD | 68 funds | $8.5B |
| NORFOLK SOUTHERN CORPNSC | 65 funds | $7.1B |
| AMAZON.COM INCAMZN | 63 funds | $105.3B |
| KENVUE INCKVUE | 63 funds | $4.3B |
| MICROSOFT CORPMSFT | 62 funds | $146.8B |
| ELI LILLY & COLLY | 61 funds | $43.5B |
| UNITEDHEALTH GROUP INCUNH | 61 funds | $17.3B |
| AT&T INCT | 61 funds | $5.5B |
| WESTERN DIGITAL CORPWDC | 61 funds | $4.5B |
| NVIDIA CORPNVDA | 60 funds | $216.2B |
| META PLATFORMS INC-CLASS AMETA | 60 funds | $62.6B |
Ranked by how many of RNA's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jan 21, 2026 | McCarthy Teresa | Chief Human Resources Officer | Sell (S) | 1K | $107K |
| Jan 21, 2026 | McCarthy Teresa | Chief Human Resources Officer | Sell (S) | 1K | $105K |
| Jan 21, 2026 | LEVIN ARTHUR A | Director | Sell (S) | 2K | $127K |
| Jan 21, 2026 | MacLean Michael F | Chief Financial Officer | Sell (S) | 3K | $198K |
| Jan 21, 2026 | MacLean Michael F | Chief Financial Officer | Sell (S) | 2K | $131K |
| Jan 21, 2026 | Flanagan W. Michael | Chief Scientific Officer | Sell (S) | 3K | $185K |
| Jan 21, 2026 | Flanagan W. Michael | Chief Scientific Officer | Sell (S) | 4K | $288K |
| Jan 21, 2026 | Boyce Sarah | President and CEO, Director | Sell (S) | 6K | $463K |
| Jan 21, 2026 | Boyce Sarah | President and CEO, Director | Sell (S) | 8K | $579K |
| Jan 21, 2026 | Hughes Steven George | Chief Medical Officer | Sell (S) | 2K | $146K |
| Jan 21, 2026 | Hughes Steven George | Chief Medical Officer | Sell (S) | 3K | $209K |
| Jan 7, 2026 | Flanagan W. Michael | Chief Scientific Officer | Sell (S) | 2K | $171K |
Connected entities for RNA
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/RNA/capital-change-brief"
Use Arkolith's capital_change_brief for RNA. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for RNA. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.